This trade activity should not be overlooked: SELLAS Life Sciences Group Inc (SLS)

With 2.36 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.45 million shares. The 52-week range on SLS shows that it touched its highest point at $1.91 and its lowest point at $0.50 during that stretch. It currently has a 1-year price target of $5.75. Beta for the stock currently stands at 2.37.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of SLS was up-trending over the past week, with a rise of 13.46%, but this was up by 18.00% over a month. Three-month performance surged to 11.32% while six-month performance fell -28.05%. The stock lost -14.49% in the past year, while it has gained 11.32% so far this year. A look at the trailing 12-month EPS for SLS yields -1.36 with Next year EPS estimates of -1.01.

Float and Shares Shorts:

At present, 56.27 million SLS shares are outstanding with a float of 55.75 million shares on hand for trading. On Mar 15, 2024, short shares totaled 5.18 million, which was 11.73% higher than short shares on Feb 15, 2024. In addition to SLV as the firm’s iShares Silver Trust, SLB serves as its Schlumberger N.V.

Institutional Ownership:

Through their ownership of 10.68% of SLS’s outstanding shares, institutional investors have minority control over the company.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for SLS since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.

Dividends & Yield:

In terms of dividends, SLS has a current ratio of $––, which is $–– over the trailing 12-months, while a dividend of $–– is likely to be paid on average over the next five years. Dividend yield is another indicator that appeals to many investors, and SLS currently yields $0.00. In the past year, SLS’s dividend yield has been $0.00, but when looking at the stock over the past five years, its yield has been $–. Accordingly, SLS has a current buyback yield of $––. This was $–– for the TTM, and it was $–– for the past five years.